Drug Pricing
The Multi-Billion Dollar Question: How a US-UK Trade Deal Could Reshape NHS Drug Pricing and Your Portfolio
A US-UK trade deal could dismantle the NHS’s drug pricing model, creating massive financial risks and unique investment opportunities.
The Ozempic Price War: How a 71% Medicare Discount is Reshaping Healthcare Finance
A landmark 71% Medicare price cut on Ozempic and Wegovy signals a major shift in healthcare finance, impacting investors, the economy, and Big Pharma.